Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status

Epidermal growth factor receptor tyrosine-kinase inhibitors (EGFR-TKIs) are standard treatment for advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation. However, EGFR mutation testing is not attainable in approximately 20% of patients. The curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Hong, Li, Wei, Ma, Zhiyong, Huang, Jianjin, Feng, Jifeng, Song, Yong, Gao, Beili, Zhu, Huili, Tao, Min, Bai, Chong, Ma, Shenglin, Pan, Hongming, Qin, Shukui, Hua, Dong, Yu, Yongfeng, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559626/
https://www.ncbi.nlm.nih.gov/pubmed/28814805
http://dx.doi.org/10.1038/s41598-017-08399-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559626/
https://www.ncbi.nlm.nih.gov/pubmed/28814805
http://dx.doi.org/10.1038/s41598-017-08399-8

Ejemplares similares